Logo

American Heart Association

  35
  0


Final ID:

Genetics in Heart Failure: Most has been sequenced. What's to be interpreted?

  • Tang, Yida  ( Peking University , Beijin , China )
  • Mestroni, Luisa  ( University of Colorado Asnchutz , Aurora , Colorado , United States )
  • Taylor, Matthew  ( University of Colorado , Boulder , Colorado , United States )
  • Ashley, Euan  ( Stanford University , Palo Alto , California , United States )
  • Author Disclosures:
    yida tang: No Answer | Luisa Mestroni: DO have relevant financial relationships ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Researcher:Greenstone Bio:Active (exists now) ; Advisor:Alexion:Active (exists now) ; Advisor:Rocket Biopharma:Active (exists now) ; Advisor:Tenaya Therapeutics:Active (exists now) | Matthew Taylor: DO have relevant financial relationships ; Consultant:Rocket Pharmaceuticals:Active (exists now) | Euan Ashley: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

2025-2035: Questions to be Addressed in Heart Failure Research in the Next 10 Years

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
Genetic Influence in Patients Transplanted for Myocarditis in the TOPMed-TOPCHeF Cohort of Explanted Hearts

Jason Max, Mestroni Luisa, Taylor Matthew, Lombardi Raffaella, Graw Sharon, Medo Kristen, Newman Sarah, Bristow Michael, Ambardekar Amrut, Cleveland Joseph, Buttrick Peter

Discussant: Danon Disease Phase 1 RP-A501

Gillmore Julian, Taylor Matthew, Adler Eric

You have to be authorized to contact abstract author. Please, Login
Not Available